Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway

Nature Communications

Volumn 6, Issue , 2015, Pages

  Song, Wei ^a   Liu, Wenjie ^a   Zhao, Hong ^b   Li, Shangze ^c   Guan, Xin ^a   Ying, Jianming ^b   Zhang, Yefan ^b   Miao, Fei ^a   Zhang, Mengmeng ^a   Ren, Xiaoxia ^a   Li, Xiaolu ^a   Wu, Fan ^a   Zhao, Yuechao ^a   Tian, Yuanyuan ^a   Wu, Wenming ^a   Fu, Jun ^a   Liang, Junbo ^a   Wu, Wei ^a   Liu, Changzheng ^a   Yu, Jia ^d   Zong, Shudong ^e   Miao, Shiying ^a   Zhang, Xiaodong ^c   Wang, Linfang ^a   more..

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CANCER HOSPITAL   (China)

^c WUHAN UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; AMPHIREGULIN; BETACELLULIN; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; GLUTATHIONE TRANSFERASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; RHOMBOID DOMAIN CONTAINING 1 PROTEIN; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; RHBDD1 PROTEIN, HUMAN;

BIOMARKER; CANCER; CELLS AND CELL COMPONENTS; DRUG; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH; METABOLISM; MOLECULAR ANALYSIS; PROTEIN; RODENT; SURVIVAL; TUMOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOPLASM; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; ENZYME INACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR GROWTH; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PHYSIOLOGY; PLASMID; TUMOR CELL LINE;

MURINAE;

ANIMALS; CELL LINE, TUMOR; COLITIS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED C57BL; MICE, NUDE; PLASMIDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84940055416     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9022     Document Type: Article

References (47)

1. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010).
2. Derynck, R., Roberts, A. B., Winkler, M. E., Chen, E. Y. & Goeddel, D. V. Human transforming growth factor-Alpha: precursor structure and expression in E. coli. Cell 38, 287-297 (1984).
3. Peschon, J. J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998).
4. Riese, D. J. et al. The epidermal growth factor receptor couples transforming growth factor-Alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271, 20047-20052 (1996).
5. Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L. & Lee, D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61, 1121-1135 (1990).
6. Jhappan, C. et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61, 1137-1146 (1990).
7. Ziober, B. L., Willson, J. K., Hymphrey, L. E., Childress-Fields, K. & Brattain, M. G. Autocrine transforming growth factor-Alpha is associated with progression of transformed properties in human colon cancer cells. J. Biol. Chem. 268, 691-698 (1993).
8. Urban, S. Rhomboid proteins: conserved membrane proteases with divergent biological functions. Genes Dev. 20, 3054-3068 (2006).
9. Bang, A. G. & Kintner, C. Rhomboid and Star facilitate presentation and processing of the Drosophila TGF-Alpha homolog Spitz. Genes Dev. 14, 177-186 (2000).
10. Wasserman, J. D., Urban, S. & Freeman, M. A family of rhomboid-like genes: Drosophila rhomboid-1 and roughoid/rhomboid-3 cooperate to activate EGF receptor signaling. Genes Dev. 14, 1651-1663 (2000).
11. Dutt, A., Canevascini, S., Froehli-Hoier, E. & Hajnal, A. EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid. PLoS Biol. 2, e334 (2004).
12. Sahin, U. et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell. Biol. 164, 769-779 (2004).
13. Adrain, C. et al. Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep. 12, 421-427 (2011).
14. Salomon, D. S., Brandt, R., Ciardiello, F. & Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19, 183-232 (1995).
15. Zou, H. et al. Human rhomboid family-1 gene RHBDF1 participates in GPCRmediated transactivation of EGFR growth signals in head and neck squamous cancer cells. FASEB J. 23, 425-432 (2009).
16. Abba, M. C. et al. Rhomboid domain containing 2 (RHBDD2): a novel cancerrelated gene over-expressed in breast cancer. Biochim. Biophys. Acta. 1792, 988-997 (2009).
17. Yan, Z. et al. Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol. Cancer Ther. 7, 1355-1364 (2008).
18. Iram, S. H. & Cole, S. P. Mutation of Glu521 or Glu535 in cytoplasmic loop 5 causes differential misfolding in multiple domains of multidrug and organic anion transporter MRP1 (ABCC1). J. Biol. Chem. 287, 7543-7555 (2012).
19. Lohi, O., Urban, S. & Freeman, M. Diverse substrate recognition mechanisms for rhomboids; thrombomodulin is cleaved by Mammalian rhomboids. Curr. Biol. 14, 236-241 (2004).
20. Pascall, J. C. & Brown, K. D. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem. Biophys. Res. Commun. 317, 244-252 (2004).
21. Urban, S. & Freeman, M. Substrate specificity of rhomboid intramembrane proteases is governed by helix-breaking residues in the substrate transmembrane domain. Mol. Cell 11, 1425-1434 (2003).
22. Strisovsky, K., Sharpe, H. J. & Freeman, M. Sequence-specific intramembrane proteolysis: identification of a recognition motif in rhomboid substrates. Mol. Cell 36, 1048-1059 (2009).
23. Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398 (2000).
24. Urban, S. & Freeman, M. Intramembrane proteolysis controls diverse signalling pathways throughout evolution. Curr. Opin. Genet. Dev. 12, 512-518 (2002).
25. Wolfe, M. S. & Kopan, R. Intramembrane proteolysis: theme and variations. Science 305, 1119-1123 (2004).
26. McIlwain, D. R. et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229-232 (2012).
27. Adrain, C., Zettl, M., Christova, Y., Taylor, N. & Freeman, M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228 (2012).
28. Zettl, M., Adrain, C., Strisovsky, K., Lastun, V. & Freeman, M. Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell 145, 79-91 (2011).
29. Cipolat, S. et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126, 163-175 (2006).
30. Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell. Biol. 191, 933-942 (2010).
31. Shi, G. et al. Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum. Mol. Genet. 20, 1966-1974 (2011).
32. Wang, Y. et al. A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis. Cell. Mol. Life Sci. 65, 3822-3829 (2008).
33. Wang, Y. et al. GC-1 mRHBDD1 knockdown spermatogonia cells lose their spermatogenic capacity in mouse seminiferous tubules. BMC Cell Biol. 10, 25 (2009).
34. Wan, C. et al. Exosome-related multi-pass transmembrane protein TSAP6 is a target of rhomboid protease RHBDD1-induced proteolysis. PloS ONE 7, e37452 (2012).
35. Rutledge, B. J., Zhang, K., Bier, E., Jan, Y. N. & Perrimon, N. The Drosophila spitz gene encodes a putative EGF-like growth factor involved in dorsal-ventral axis formation and neurogenesis. Genes Dev. 6, 1503-1517 (1992).
36. Neuman-Silberberg, F. S. & Schupbach, T. The Drosophila dorsoventral patterning gene gurken produces a dorsally localized RNA and encodes a TGF alpha-like protein. Cell 75, 165-174 (1993).
37. Schnepp, B., Grumbling, G., Donaldson, T. & Simcox, A. Vein is a novel component in the Drosophila epidermal growth factor receptor pathway with similarity to the neuregulins. Genes Dev. 10, 2302-2313 (1996).
38. Sunnarborg, S. W. et al. Tumor necrosis factor-Alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838-12845 (2002).
39. Hinkle, C. L. et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279, 24179-24188 (2004).
40. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
41. Coffey, Jr. R. J. et al. Production and auto-induction of transforming growth factor-Alpha in human keratinocytes. Nature 328, 817-820 (1987).
42. Bates, S. E. et al. Expression of the transforming growth factor-Alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology 126, 596-607 (1990).
43. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (1989).
44. Harvey, J. M., Clark, G. M., Osborne, C. K. & Allred, D. C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J. Clin. Oncol. 17, 1474-1481 (1999).
45. Zhang, P. et al. Cross-talk between phospho-STAT3 and PLCgamma1 plays a critical role in colorectal tumorigenesis. Mol. Cancer Res. 9, 1418-1428 (2011).
46. Zhang, X. et al. Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies. Nat. Methods 5, 163-165 (2008).
47. Wang, H. et al. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway. Cell. Mol. Life Sci. 68, 2129-2139 (2011).